[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Shishito et al., 1971 - Google Patents

Postoperative Course and Treatment in Adrenal Surgery: II. Cushing's Syndrome and Pheochromocytoma

Shishito et al., 1971

Document ID
9662848649880614455
Author
Shishito S
Watanabe H
Publication year
Publication venue
Urologia Internationalis

External Links

Snippet

A simplified and standardized pre-and postoperative treatment technique for Cushing's syndrome and pheochromocytoma was discussed from experiences on 21 and 18 cases, respectively, treated in our clinic since 1956. Results were summarized as follows …
Continue reading at karger.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones

Similar Documents

Publication Publication Date Title
Hodsman et al. Factors related to first dose hypotensive effect of captopril: prediction and treatment.
Hench et al. Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases
Pierpont et al. Effect of captopril on renal function in patients with congestive heart failure.
Textor et al. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril
ELLIS et al. Postural hypotension: with particular reference to its occurrence in disease of the central nervous system
Arroyo albumin in the treatment of liver diseases—new features of a classical treatment
HAKSTIAN et al. Pharmacological Agents in Experimental Hemorrhagic Shock: A Controlled Comparison of Treatment with Hydralazine, Hydrocortisone, and Levarterenol (l-Norepinephrine)
Hodsman et al. Enalapril in treatment of hypertension with renal artery stenosis: changes in blood pressure, renin, angiotensin I and II, renal function, and body composition
Shishito et al. Postoperative Course and Treatment in Adrenal Surgery: II. Cushing’s Syndrome and Pheochromocytoma
Hasser et al. Osmotically released vasopressin augments cardiopulmonary reflex inhibition of the circulation
Currens et al. The use of protoveratrine in the treatment of hypertensive vascular disease
Seltzer et al. Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass
EP1223968A2 (en) Use of urodilatin for treating chronic kidney failure with residual kidney functions
Söder et al. Treatment of Pre‐eclampsia and Eclampsia as a Hypoperfusion Syndrome
Caramelli et al. Treatment of atrioventricular block with prednisone∗
Quadri et al. Augmentation of heme oxygenase promotes acute angiotensin II induced hypertension
Van Cauwenberge et al. Prothrombin time and hemorrhagic death in dicumarolized rats receiving pituitary and adrenal hormones
Aurell et al. Captopril treatment in hypertensive dialysis patients
Witzgall Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysis
Atkinson et al. Combined captopril and spironolactone treatment in Conn's syndrome with renal impairment and refractory hypertension
Van Hoogdalem et al. Partial correction of hypertension by angiotensin II blockade in a patient with phaeochromocytoma
Aronow et al. Effect of timolol plus hydrochlorothiazide plus hydralazine on essential hypertension.
Bartels et al. Chlorothiazide—a survey of its effects in hypertensive patients
Salvetti et al. Acute hemodynamic effect of nifedipine in hypertensives with chronic renal failure: The influence of volume status
Zachariah et al. Stimulation of plasma renin activity by captopril in renovascular hypertensive conscious dogs